| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4531369
Max Phase: Preclinical
Molecular Formula: C17H16BrN
Molecular Weight: 314.23
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: CN(CC#Cc1ccccc1)Cc1ccc(Br)cc1
Standard InChI: InChI=1S/C17H16BrN/c1-19(14-16-9-11-17(18)12-10-16)13-5-8-15-6-3-2-4-7-15/h2-4,6-7,9-12H,13-14H2,1H3
Standard InChI Key: OPOATFCKYGZZCK-UHFFFAOYSA-N
Associated Targets(Human)
Pyrroline-5-carboxylate reductase 1, mitochondrial 71 Activities
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 314.23 | Molecular Weight (Monoisotopic): 313.0466 | AlogP: 3.93 | #Rotatable Bonds: 3 |
| Polar Surface Area: 3.24 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
| #RO5 Violations: 0 | HBA (Lipinski): 1 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: | CX Basic pKa: 7.56 | CX LogP: 4.88 | CX LogD: 4.49 |
| Aromatic Rings: 2 | Heavy Atoms: 19 | QED Weighted: 0.78 | Np Likeness Score: -1.11 |
References
| 1. Milne K, Sun J, Zaal EA, Mowat J, Celie PHN, Fish A, Berkers CR, Forlani G, Loayza-Puch F, Jamieson C, Agami R.. (2019) A fragment-like approach to PYCR1 inhibition., 29 (18): [PMID:31362921] [10.1016/j.bmcl.2019.07.047] |
Source
Source(1):